These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19016753)

  • 1. ITCH is a putative target for a novel 20q11.22 amplification detected in anaplastic thyroid carcinoma cells by array-based comparative genomic hybridization.
    Ishihara T; Tsuda H; Hotta A; Kozaki K; Yoshida A; Noh JY; Ito K; Imoto I; Inazawa J
    Cancer Sci; 2008 Oct; 99(10):1940-9. PubMed ID: 19016753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Array-CGH identifies cyclin D1 and UBCH10 amplicons in anaplastic thyroid carcinoma.
    Lee JJ; Au AY; Foukakis T; Barbaro M; Kiss N; Clifton-Bligh R; Staaf J; Borg A; Delbridge L; Robinson BG; Wallin G; Höög A; Larsson C
    Endocr Relat Cancer; 2008 Sep; 15(3):801-15. PubMed ID: 18753363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular cytogenetic profiles of novel and established human anaplastic thyroid carcinoma models.
    Lee JJ; Foukakis T; Hashemi J; Grimelius L; Heldin NE; Wallin G; Rudduck C; Lui WO; Höög A; Larsson C
    Thyroid; 2007 Apr; 17(4):289-301. PubMed ID: 17465858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel amplification target, DUSP26, promotes anaplastic thyroid cancer cell growth by inhibiting p38 MAPK activity.
    Yu W; Imoto I; Inoue J; Onda M; Emi M; Inazawa J
    Oncogene; 2007 Feb; 26(8):1178-87. PubMed ID: 16924234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic amplification of long noncoding RNA HOTAIRM1 drives anaplastic thyroid cancer progression via repressing miR-144 biogenesis.
    Zhang L; Zhang J; Li S; Zhang Y; Liu Y; Dong J; Zhao W; Yu B; Wang H; Liu J
    RNA Biol; 2021 Apr; 18(4):547-562. PubMed ID: 32951513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrations of chromosomes 5 and 8 as recurrent cytogenetic events in anaplastic carcinoma of the thyroid as detected by fluorescence in situ hybridisation and comparative genomic hybridisation.
    Wilkens L; Benten D; Tchinda J; Brabant G; Pötter E; Dralle H; von Wasielewski R
    Virchows Arch; 2000 Apr; 436(4):312-8. PubMed ID: 10834532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXA1 is a potential oncogene in anaplastic thyroid carcinoma.
    Nucera C; Eeckhoute J; Finn S; Carroll JS; Ligon AH; Priolo C; Fadda G; Toner M; Sheils O; Attard M; Pontecorvi A; Nose V; Loda M; Brown M
    Clin Cancer Res; 2009 Jun; 15(11):3680-9. PubMed ID: 19470727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpressed in anaplastic thyroid carcinoma-1 (OEATC-1) as a novel gene responsible for anaplastic thyroid carcinoma.
    Mizutani K; Onda M; Asaka S; Akaishi J; Miyamoto S; Yoshida A; Nagahama M; Ito K; Emi M
    Cancer; 2005 May; 103(9):1785-90. PubMed ID: 15789362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative genomic hybridization defines frequent loss on 16p in human anaplastic thyroid carcinoma.
    Komoike Y; Tamaki Y; Sakita I; Tomita N; Ohue M; Sekimoto M; Miyazaki M; Kadota M; Masuda N; Ooka M; Ohnishi T; Nakano Y; Kozaki T; Kobayashi T; Matsuura N; Ikeda T; Horii A; Monden M
    Int J Oncol; 1999 Jun; 14(6):1157-62. PubMed ID: 10339673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of an inhibitor of cell growth, transmembrane protein 34 (TMEM34), in anaplastic thyroid cancer.
    Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K
    J Cancer Res Clin Oncol; 2007 Apr; 133(4):213-8. PubMed ID: 17072649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines.
    Mitomo S; Maesawa C; Ogasawara S; Iwaya T; Shibazaki M; Yashima-Abo A; Kotani K; Oikawa H; Sakurai E; Izutsu N; Kato K; Komatsu H; Ikeda K; Wakabayashi G; Masuda T
    Cancer Sci; 2008 Feb; 99(2):280-6. PubMed ID: 18201269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of the CBX7 gene expression correlates with a highly malignant phenotype in thyroid cancer.
    Pallante P; Federico A; Berlingieri MT; Bianco M; Ferraro A; Forzati F; Iaccarino A; Russo M; Pierantoni GM; Leone V; Sacchetti S; Troncone G; Santoro M; Fusco A
    Cancer Res; 2008 Aug; 68(16):6770-8. PubMed ID: 18701502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mRNA expression in papillary and anaplastic thyroid carcinoma: molecular anatomy of a killing switch.
    Hébrant A; Dom G; Dewaele M; Andry G; Trésallet C; Leteurtre E; Dumont JE; Maenhaut C
    PLoS One; 2012; 7(10):e37807. PubMed ID: 23115614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of SMURF1 as a possible target for 7q21.3-22.1 amplification detected in a pancreatic cancer cell line by in-house array-based comparative genomic hybridization.
    Suzuki A; Shibata T; Shimada Y; Murakami Y; Horii A; Shiratori K; Hirohashi S; Inazawa J; Imoto I
    Cancer Sci; 2008 May; 99(5):986-94. PubMed ID: 18380791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 constrains progression to anaplastic thyroid carcinoma in a Braf-mutant mouse model of papillary thyroid cancer.
    McFadden DG; Vernon A; Santiago PM; Martinez-McFaline R; Bhutkar A; Crowley DM; McMahon M; Sadow PM; Jacks T
    Proc Natl Acad Sci U S A; 2014 Apr; 111(16):E1600-9. PubMed ID: 24711431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-level genomic instability is a feature of papillary thyroid carcinoma: an array comparative genomic hybridization study of laser capture microdissected papillary thyroid carcinoma tumors and clonal cell lines.
    Finn S; Smyth P; O'Regan E; Cahill S; Toner M; Timon C; Flavin R; O'Leary J; Sheils O
    Arch Pathol Lab Med; 2007 Jan; 131(1):65-73. PubMed ID: 17227125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokeratin-8 in Anaplastic Thyroid Carcinoma: More Than a Simple Structural Cytoskeletal Protein.
    Guo D; Xu Q; Pabla S; Koomen J; Biddinger P; Sharma A; Pabla S; Pacholczyk R; Chang CC; Friedrich K; Mohammed K; Smallridge RC; Copland JA; She JX; Weinberger PM
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29443941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of cell cycle mediator protein expression patterns in anaplastic and papillary thyroid carcinoma.
    Evans JJ; Crist HS; Durvesh S; Bruggeman RD; Goldenberg D
    Cancer Biol Ther; 2012 Jul; 13(9):776-81. PubMed ID: 22688732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification of thymosin beta 10 and AKAP13 genes in metastatic and aggressive papillary thyroid carcinomas.
    Fehér LZ; Pocsay G; Krenács L; Zvara A; Bagdi E; Pocsay R; Lukács G; Győry F; Gazdag A; Tarkó E; Puskás LG
    Pathol Oncol Res; 2012 Apr; 18(2):449-58. PubMed ID: 22161024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Super-Enhancer-Driven Oncogenic Transcription by CDK7 Inhibition in Anaplastic Thyroid Carcinoma.
    Cao X; Dang L; Zheng X; Lu Y; Lu Y; Ji R; Zhang T; Ruan X; Zhi J; Hou X; Yi X; Li MJ; Gu T; Gao M; Zhang L; Chen Y
    Thyroid; 2019 Jun; 29(6):809-823. PubMed ID: 30924726
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.